Early Trial Tests Ontorpacept Plus Doxorubicin for Advanced Leiomyosarcoma
A new Phase 1/2 clinical study is testing whether an immune-targeting drug can make chemotherapy more effective against high-grade leiomyosarcoma, ...
A new Phase 1/2 clinical study is testing whether an immune-targeting drug can make chemotherapy more effective against high-grade leiomyosarcoma, ...
In a groundbreaking study published in Cell Death Discovery, researchers have unveiled IOA-244, a novel and highly selective inhibitor of ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine